INDIANAPOLIS, Ind. (ADAMS) – Pharmaceutical giant Eli Lilly will put over $5 billion into expanding manufacturing in Indiana.
The company says it will be doubling its investment in a site near their headquarters in Indianapolis that is expected to start making products by the end of 2026.
The manufacturing plant in Lebanon, Indiana will make doses of the weight loss and diabetes medications, Zepbound and Mounjaro.
Read more here
Comments